Onorach Clinical Ltd   Report issue

For profit Phase 2
Founded: Dundee United Kingdom (2009)

Organization Overview

First Clinical Trial
2014
NCT03311178
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Onorach Clinical | Onorach Clinical Dundee, Scotland | Onorach Clinical Ltd

Active Ingredients

Drugs in Phase 2 Trials (1)

dobutamine (dobutrex) (1 trial)

Drugs in Other Trials (1)

bifidobacterium animalis (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Shock (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2